title: HLA-A*31:01 and methotrexate-induced interstitial lung disease in Japanese rheumatoid arthritis patients: a multidrug hypersensitivity marker?
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Furukawa
authors.forename: Shomi
authors.initials: S
authors.lastname: Oka
authors.forename: Kota
authors.initials: K
authors.lastname: Shimada
authors.forename: Naoyuki
authors.initials: N
authors.lastname: Tsuchiya
authors.forename: Shigeto
authors.initials: S
authors.lastname: Tohma
mesh_terms: D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000235:genetics; D044466:Asian People; D016022:Case-Control Studies; D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics; D005838:Genotype; D015234:HLA-A Antigens / Q000235:genetics*; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000139:chemically induced* / Q000235:genetics*; D008297:Male; D008727:Methotrexate / Q000009:adverse effects*; D008875:Middle Aged
chemical_list: D018501:Antirheumatic Agents; D015234:HLA-A Antigens; C506273:HLA-A*31:01 antigen; D008727:Methotrexate